300294 博雅生物
按盤價 
18.610 -0.500 (-2.616%)
18.610 -0.500 (-2.616%) | 2025/12 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 1.510 | 5.362 | 3.274 | 6.168 | 6.300 |
| 總資產報酬率 ROA (%) | 1.324 | 4.892 | 2.994 | 5.522 | 5.392 |
| 投入資產回報率 ROIC (%) | 1.436 | 5.204 | 3.233 | 6.081 | 6.013 | 邊際利潤分析 |
| 銷售毛利率 (%) | 49.894 | 64.654 | 52.758 | 54.657 | 56.982 |
| 營業利潤率 (%) | 5.314 | 27.509 | 13.395 | 19.291 | 16.716 |
| 息稅前利潤/營業總收入 (%) | 4.138 | 26.061 | 12.188 | 18.368 | 15.941 |
| 淨利潤/營業總收入 (%) | 5.470 | 22.856 | 9.357 | 16.148 | 13.517 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 308.293 | 95.379 | 159.564 | 100.786 | 108.372 |
| 價值變動淨收益/利潤總額(%) | 80.656 | 16.463 | 28.201 | 8.240 | 9.729 |
| 營業外收支淨額/利潤總額(%) | -5.337 | 0.096 | -0.428 | -0.034 | 0.014 | 償債能力分析 |
| 流動比率 (X) | 5.063 | 6.741 | 14.082 | 8.611 | 8.948 |
| 速動比率 (X) | 4.099 | 5.415 | 12.862 | 7.665 | 7.876 |
| 資產負債率 (%) | 13.760 | 10.872 | 6.490 | 9.316 | 9.201 |
| 帶息債務/全部投入資本 (%) | 3.861 | 2.518 | 0.830 | 0.708 | 0.819 |
| 股東權益/帶息債務 (%) | 2,455.063 | 3,788.901 | 11,905.027 | 13,936.386 | 12,032.500 |
| 股東權益/負債合計 (%) | 626.602 | 819.717 | 1,440.684 | 960.198 | 973.774 |
| 利息保障倍數 (X) | -4.566 | -17.680 | -10.600 | -20.046 | -20.505 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 108.031 | 68.301 | 45.580 | 59.165 | 60.914 |
| 存貨周轉天數 (天) | 347.471 | 455.674 | 175.840 | 193.372 | 215.694 |
| 備註： | 報價延遲最少15分鐘，資料更新時間為 03/04/2026 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
